155 related articles for article (PubMed ID: 7779735)
1. Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.
Vessey MP; Painter R
Br J Cancer; 1995 Jun; 71(6):1340-2. PubMed ID: 7779735
[TBL] [Abstract][Full Text] [Related]
2. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
4. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Jareid M; Thalabard JC; Aarflot M; Bøvelstad HM; Lund E; Braaten T
Gynecol Oncol; 2018 Apr; 149(1):127-132. PubMed ID: 29482839
[TBL] [Abstract][Full Text] [Related]
6. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
7. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D
Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572
[TBL] [Abstract][Full Text] [Related]
8. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
9. Epithelial ovarian cancer and combination oral contraceptives.
Rosenberg L; Shapiro S; Slone D; Kaufman DW; Helmrich SP; Miettinen OS; Stolley PD; Rosenshein NB; Schottenfeld D; Engle RL
JAMA; 1982 Jun; 247(23):3210-2. PubMed ID: 7045417
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
[TBL] [Abstract][Full Text] [Related]
11. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
Vessey M; Yeates D
Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
[TBL] [Abstract][Full Text] [Related]
14. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
16. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
Villard-Mackintosh L; Vessey MP; Jones L
Br J Obstet Gynaecol; 1989 Jul; 96(7):783-8. PubMed ID: 2788456
[TBL] [Abstract][Full Text] [Related]
17. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives.
Vessey M; Metcalfe A; Wells C; McPherson K; Westhoff C; Yeates D
Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1518-20. PubMed ID: 3111618
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the association of oral contraceptives and ovarian cancer.
Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
[TBL] [Abstract][Full Text] [Related]
19. The risk of epithelial ovarian cancer in short-term users of oral contraceptives.
Gross TP; Schlesselman JJ; Stadel BV; Yu W; Lee NC
Am J Epidemiol; 1992 Jul; 136(1):46-53. PubMed ID: 1415131
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and breast cancer: latest findings in a large cohort study.
Vessey MP; McPherson K; Villard-Mackintosh L; Yeates D
Br J Cancer; 1989 Apr; 59(4):613-7. PubMed ID: 2713247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]